<DOC>
	<DOCNO>NCT00893880</DOCNO>
	<brief_summary>A multi-arm trial evaluate efficacy safety use gaseous nitric oxide treat moderate severe tinea pedis .</brief_summary>
	<brief_title>A Dose Response Trial Evaluate Clinical Mycological Effect Nitric Oxide Subjects With Tinea Pedis</brief_title>
	<detailed_description />
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Positive clinical finding ( moderate severe , indicate CSSS ≥ 6 ) interdigital bullous tinea pedis determine clinical examination ( subject moccasin symptom addition may also include discretion investigator ) . Written informed consent must obtain subject . Must ≥ 18 year age , unless local law dictate otherwise . Must agree avoid professional pedicure application nail polish product nail cosmetic toenail screen visit conclusion trial . Must pregnant nursing , childbearing potential , agree take measure avoid pregnancy study period Has diagnosis either psoriasis eczema , immediately around area evaluation . Has visual diagnosis , investigator , onychomycosis level , opinion investigator would compromise integrity study . Use topical antifungal e.g . ( clotrimazole , ketoconazole , miconazole , oxiconazole ( Oxistat® , Glaxo Smith Kline ) , sulconazole , naftifine ( Naftin® , Merz ) , terconazole , econazole nitrate ( Spectazole® , OrthoMcNeil ) , butoconazole , Fluconazole , ciclopirox olamine ( Loprox® , Medicis ) , tolnaftate , haloprogin ) , ZeasorbAF , antibacterial corticosteroids precede 14 day screen visit ( Day 1 ) , immediately around area evaluation . Use oral injectable systemic corticosteroid precede 7 30 day respectively , screen visit ( Day 1 ) Use systemic antifungal precede 30 day screen visit ( Day1 ) include ( terbinafine ( Lamisil® , Novartis ) , Itraconazole ( Sporanox® , Janssen ) , fluconazole ( Diflucan® , Pfizer ) , ketoconazole , miconazole , griseofulvin ( GrisPEG® , Pedinol ) , butoconazole , terconazole , Potassium iodide ) Has use investigational drug ( ) within 30 day precede screen visit ( Day 1 ) Is pregnant nursing mother Is woman child bear potential use adequate form contraception ( abstinence ) Is &lt; 18 year age , unless local law dictate otherwise . Is immunosuppressed ( undergoing chemotherapy , neutropenia ( PMNs , &lt; 500/mm3 ) , HIV CD4+ &lt; 200/mm3 . Suffers condition , , opinion medical investigator , would compromise his/her safety / quality data . Such condition may include collagen vascular disease , diabetes mellitus , Cushing 's Disease , hematological malignancy , chronic mucocutaneous candidiasis atopy STATISTICS This clinical evaluation intend demonstrate</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Tinea Pedis</keyword>
	<keyword>Athletes Foot</keyword>
	<keyword>Nitric Oxide</keyword>
</DOC>